IL308124A - Micronized lipids - Google Patents

Micronized lipids

Info

Publication number
IL308124A
IL308124A IL308124A IL30812423A IL308124A IL 308124 A IL308124 A IL 308124A IL 308124 A IL308124 A IL 308124A IL 30812423 A IL30812423 A IL 30812423A IL 308124 A IL308124 A IL 308124A
Authority
IL
Israel
Prior art keywords
micronized
lipids
micronized lipids
Prior art date
Application number
IL308124A
Other languages
Hebrew (he)
Inventor
Thomas Gadek
Original Assignee
Mcal Therapeutics Inc
Thomas Gadek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcal Therapeutics Inc, Thomas Gadek filed Critical Mcal Therapeutics Inc
Publication of IL308124A publication Critical patent/IL308124A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL308124A 2021-05-03 2021-05-03 Micronized lipids IL308124A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2021/030443 WO2022235252A1 (en) 2021-05-03 2021-05-03 Micronized lipids

Publications (1)

Publication Number Publication Date
IL308124A true IL308124A (en) 2023-12-01

Family

ID=83932912

Family Applications (1)

Application Number Title Priority Date Filing Date
IL308124A IL308124A (en) 2021-05-03 2021-05-03 Micronized lipids

Country Status (10)

Country Link
EP (1) EP4333794A1 (en)
JP (1) JP2024518440A (en)
KR (1) KR20240004849A (en)
CN (1) CN117580560A (en)
AU (1) AU2021444376A1 (en)
BR (1) BR112023022880A2 (en)
CA (1) CA3217006A1 (en)
IL (1) IL308124A (en)
MX (1) MX2023012692A (en)
WO (1) WO2022235252A1 (en)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9003100D0 (en) * 1990-09-28 1990-09-28 Kabivitrum Ab LIPID FORMULATION SYSTEM
US5558653A (en) 1995-06-07 1996-09-24 Lindstrom; Richard L. Targeted eye drop dispenser
US5578020A (en) 1995-09-01 1996-11-26 Mosley; Manuel L. Drop dispensing apparatus
US5810794A (en) 1996-11-21 1998-09-22 Peplinski; Lee S. Eye drop dispensing device
US8916539B2 (en) * 2000-01-10 2014-12-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of disease
US6736802B1 (en) 2002-12-04 2004-05-18 Shai Recanati Eye-drop applicator
US7846140B2 (en) 2004-11-30 2010-12-07 James Hagele Mini eye drop tip
US20060222716A1 (en) * 2005-04-01 2006-10-05 Joseph Schwarz Colloidal solid lipid vehicle for pharmaceutical use
US7563256B2 (en) 2006-03-30 2009-07-21 Isaac Hearne Cannula tip eye drop dispenser
US7527613B2 (en) 2006-04-05 2009-05-05 Rush University Medical Center Therapeutic solution drop dispenser
CN103417326B (en) 2012-05-25 2015-04-01 中国人民解放军军事医学科学院附属医院 Eye drops dropper
US9289494B2 (en) 2013-11-20 2016-03-22 RestorTears, LLC Method of treating ocular disorders with compounds found in Harderian gland secretions
CN105219789B (en) * 2014-06-27 2023-04-07 联邦科学技术研究组织 Extracted plant lipids comprising docosapentaenoic acid
US9072581B1 (en) 2014-09-25 2015-07-07 King Saud University Eye dropper positioning and guiding apparatus
US10265214B2 (en) 2015-08-24 2019-04-23 Magic Touch Eye, Inc. Eye drop applicator
PT3442480T (en) 2016-06-23 2019-12-23 Novaliq Gmbh Topical administration method
CN109330992B (en) * 2018-12-07 2021-04-09 中国医科大学 Polydopamine modified nano-structure lipid carrier and application thereof in intradermal drug delivery

Also Published As

Publication number Publication date
EP4333794A1 (en) 2024-03-13
MX2023012692A (en) 2024-01-19
BR112023022880A2 (en) 2024-01-23
JP2024518440A (en) 2024-05-01
AU2021444376A1 (en) 2023-11-16
CN117580560A (en) 2024-02-20
WO2022235252A1 (en) 2022-11-10
KR20240004849A (en) 2024-01-11
CA3217006A1 (en) 2022-11-10

Similar Documents

Publication Publication Date Title
IL281948A (en) Ionizable amine lipids
IL287421A (en) Ionizable amine lipids and lipid nanoparticles
IL283622A (en) Modified amine lipids
EP3959195C0 (en) Thioester cationic lipids
EP3733641A4 (en) Cationic lipids
IL275534A (en) Lysophosphatidylcholine compositions
EP4253377A4 (en) 5-heteroaryl-1h-pyrazol-3-amine derivative
CA205915S (en) Box assembly
EP3813820A4 (en) Novel lipids
IL263838A (en) Phospholipid compositions
TWI800519B (en) Side-solderable leadless package
EP3664958A4 (en) Leadless stack comprising multiple components
EP4166541A4 (en) Dimethylsulfoximine derivative
EP3569097A4 (en) Air cushion powder box
CA188709S (en) Headphones
EP3681810A4 (en) Secondary insertion feature for assembled package
IL308124A (en) Micronized lipids
GB202105209D0 (en) Electrical back box
CA201957S (en) Box
GB2597516B (en) Pattress box
GB202017470D0 (en) Antioxidant
GB2588670B (en) Electrical back box
GB202112020D0 (en) Box fast
GB202013889D0 (en) Box
GB202005598D0 (en) Box